Intravenous Iron Dextran (High Molecular Weight)
Treatment for Iron Deficiency Anemia
Typical Dosage: Variable, up to 1000 mg total in single or multiple infusions
Effectiveness
87%
Safety Score
60%
Clinical Trials
50
Participants
10K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
Variable, up to 1000 mg total in single or multiple infusions
Time to Effect
2-4 weeks
Treatment Duration
Single dose or several days
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
50(Treat 50 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$350
Monitoring:$2,600
Side Effect Mgmt:$200
Total Annual:$3,150
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$70,000/QALY
QALYs Gained
0.3
Outcome-Based Costs
Cost per Responder
$3,706
Cost per Remission
$4,065
Comparison vs Oral Ferrous Sulfate
Cost Difference
+$2,680/year
More expensive
QALY Difference
+0.10 QALYs
Better outcomes
Dominance
No dominance
Prescription Access Economics
Risk Assessment
Requires Monitoring
YesNeeds lab work/checkups
Intravenous Iron Dextran (High Molecular Weight) Outcomes
for Iron Deficiency Anemia
Efficacy Outcomes
Overall Effectiveness
+87%
Response Rate
+85%
Remission Rate
+77.5%
Common Side Effects
Fever, chills, arthralgia (iron-dextran reaction)
+7%
Hypotension
+2%
Nausea
+1%
Headache
+1%
Anaphylactic reactions
+0.6%
Skin staining (extravasation)
+0.5%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov